Literature DB >> 21572391

AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription.

Si Kee Tan1, Zhen Hua Lin, Cheng Wei Chang, Vipin Varang, Kern Rei Chng, You Fu Pan, Eu Leong Yong, Wing Kin Sung, Win King Sung, Edwin Cheung.   

Abstract

Oestrogen receptor α (ERα) is key player in the progression of breast cancer. Recently, the cistrome and interactome of ERα were mapped in breast cancer cells, revealing the importance of spatial organization in oestrogen-mediated transcription. However, the underlying mechanism of this process is unclear. Here, we show that ERα binding sites (ERBS) identified from the Chromatin Interaction Analysis-Paired End DiTag of ERα are enriched for AP-2 motifs. We demonstrate the transcription factor, AP-2γ, which has been implicated in breast cancer oncogenesis, binds to ERBS in a ligand-independent manner. Furthermore, perturbation of AP-2γ expression impaired ERα DNA binding, long-range chromatin interactions, and gene transcription. In genome-wide analyses, we show that a large number of AP-2γ and ERα binding events converge together across the genome. The majority of these shared regions are also occupied by the pioneer factor, FoxA1. Molecular studies indicate there is functional interplay between AP-2γ and FoxA1. Finally, we show that most ERBS associated with long-range chromatin interactions are colocalized with AP-2γ and FoxA1. Together, our results suggest AP-2γ is a novel collaborative factor in ERα-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21572391      PMCID: PMC3155293          DOI: 10.1038/emboj.2011.151

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1.

Authors:  Christopher R Vakoc; Danielle L Letting; Nele Gheldof; Tomoyuki Sawado; M A Bender; Mark Groudine; Mitchell J Weiss; Job Dekker; Gerd A Blobel
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

2.  Genome-wide analysis of estrogen receptor binding sites.

Authors:  Jason S Carroll; Clifford A Meyer; Jun Song; Wei Li; Timothy R Geistlinger; Jérôme Eeckhoute; Alexander S Brodsky; Erika Krasnickas Keeton; Kirsten C Fertuck; Giles F Hall; Qianben Wang; Stefan Bekiranov; Victor Sementchenko; Edward A Fox; Pamela A Silver; Thomas R Gingeras; X Shirley Liu; Myles Brown
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

3.  Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers.

Authors:  Alla V Tsytsykova; Ricardo Rajsbaum; James V Falvo; Filipa Ligeiro; Simon R Neely; Anne E Goldfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

4.  Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.

Authors:  Richard Jäger; Nicolaus Friedrichs; Inge Heim; Reinhard Büttner; Hubert Schorle
Journal:  Breast Cancer Res Treat       Date:  2005-04       Impact factor: 4.872

Review 5.  Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review.

Authors:  Johanna M Pellikainen; Veli-Matti Kosma
Journal:  Int J Cancer       Date:  2007-05-15       Impact factor: 7.396

Review 6.  RET tyrosine kinase signaling in development and cancer.

Authors:  Elena Arighi; Maria Grazia Borrello; Hannu Sariola
Journal:  Cytokine Growth Factor Rev       Date:  2005 Aug-Oct       Impact factor: 7.638

7.  TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.

Authors:  George W Woodfield; Annamarie D Horan; Yizhen Chen; Ronald J Weigel
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

8.  Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer.

Authors:  Jérôme Eeckhoute; Erika Krasnickas Keeton; Mathieu Lupien; Susan A Krum; Jason S Carroll; Myles Brown
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

Review 9.  The AP-2 family of transcription factors.

Authors:  Dawid Eckert; Sandra Buhl; Susanne Weber; Richard Jäger; Hubert Schorle
Journal:  Genome Biol       Date:  2005-12-28       Impact factor: 13.583

10.  Whole-genome cartography of estrogen receptor alpha binding sites.

Authors:  Chin-Yo Lin; Vinsensius B Vega; Jane S Thomsen; Tao Zhang; Say Li Kong; Min Xie; Kuo Ping Chiu; Leonard Lipovich; Daniel H Barnett; Fabio Stossi; Ailing Yeo; Joshy George; Vladimir A Kuznetsov; Yew Kok Lee; Tze Howe Charn; Nallasivam Palanisamy; Lance D Miller; Edwin Cheung; Benita S Katzenellenbogen; Yijun Ruan; Guillaume Bourque; Chia-Lin Wei; Edison T Liu
Journal:  PLoS Genet       Date:  2007-04-17       Impact factor: 5.917

View more
  79 in total

1.  A transcriptional repressor co-regulatory network governing androgen response in prostate cancers.

Authors:  Kern Rei Chng; Cheng Wei Chang; Si Kee Tan; Chong Yang; Shu Zhen Hong; Noel Yan Wei Sng; Edwin Cheung
Journal:  EMBO J       Date:  2012-04-24       Impact factor: 11.598

2.  A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer.

Authors:  Vincent T Wu; Boris Kiriazov; Kelsey E Koch; Vivian W Gu; Anna C Beck; Nicholas Borcherding; Tiandao Li; Peter Addo; Zachary J Wehrspan; Weizhou Zhang; Terry A Braun; Bartley J Brown; Vimla Band; Hamid Band; Mikhail V Kulak; Ronald J Weigel
Journal:  Mol Cancer Res       Date:  2019-10-16       Impact factor: 5.852

3.  Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs.

Authors:  Päivi Pihlajamaa; Biswajyoti Sahu; Lauri Lyly; Viljami Aittomäki; Sampsa Hautaniemi; Olli A Jänne
Journal:  EMBO J       Date:  2014-01-22       Impact factor: 11.598

4.  Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor.

Authors:  Philip M Spanheimer; George W Woodfield; Anthony R Cyr; Mikhail V Kulak; Lola S White-Baer; Thomas B Bair; Ronald J Weigel
Journal:  Ann Surg Oncol       Date:  2012-08-10       Impact factor: 5.344

5.  Dynamic estrogen receptor interactomes control estrogen-responsive trefoil Factor (TFF) locus cell-specific activities.

Authors:  Justine Quintin; Christine Le Péron; Gaëlle Palierne; Maud Bizot; Stéphanie Cunha; Aurélien A Sérandour; Stéphane Avner; Catherine Henry; Frédéric Percevault; Marc-Antoine Belaud-Rotureau; Sébastien Huet; Erwan Watrin; Jérôme Eeckhoute; Vincent Legagneux; Gilles Salbert; Raphaël Métivier
Journal:  Mol Cell Biol       Date:  2014-04-21       Impact factor: 4.272

6.  Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.

Authors:  Rinath Jeselsohn; MacIntosh Cornwell; Matthew Pun; Gilles Buchwalter; Mai Nguyen; Clyde Bango; Ying Huang; Yanan Kuang; Cloud Paweletz; Xiaoyong Fu; Agostina Nardone; Carmine De Angelis; Simone Detre; Andrew Dodson; Hisham Mohammed; Jason S Carroll; Michaela Bowden; Prakash Rao; Henry W Long; Fugen Li; Mitchell Dowsett; Rachel Schiff; Myles Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

Review 7.  Deciphering cis-regulatory control in inflammatory cells.

Authors:  Serena Ghisletti; Gioacchino Natoli
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-05-06       Impact factor: 6.237

8.  Histone demethylase KDM5B collaborates with TFAP2C and Myc to repress the cell cycle inhibitor p21(cip) (CDKN1A).

Authors:  Ping-Pui Wong; Fabrizio Miranda; KaYi V Chan; Chiara Berlato; Helen C Hurst; Angelo G Scibetta
Journal:  Mol Cell Biol       Date:  2012-02-27       Impact factor: 4.272

9.  Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells.

Authors:  Livia Caizzi; Giulio Ferrero; Santina Cutrupi; Francesca Cordero; Cecilia Ballaré; Valentina Miano; Stefania Reineri; Laura Ricci; Olivier Friard; Alessandro Testori; Davide Corà; Michele Caselle; Luciano Di Croce; Michele De Bortoli
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

10.  Amplitude modulation of androgen signaling by c-MYC.

Authors:  Min Ni; Yiwen Chen; Teng Fei; Dan Li; Elgene Lim; X Shirley Liu; Myles Brown
Journal:  Genes Dev       Date:  2013-03-25       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.